title: Merck: A Golden Buying Opportunity
source: SeekingAlpha
date: 2025-10-15
url: https://finnhub.io/api/news?id=d12ee016efeb7b58c12f7d6d21079609725ba2916e9d1a8623f1954cccd993c0
Merck's strong drug pipeline, oncology leadership, and 3.8% dividend yield make it a top long-term investment pick. Learn more about MRK stock here.
